Investing Profile

Raphael Wisniewski

InvestorVC
Associate at Andera Partners
anderapartners.com/en/team/ra...Paris, France
Photo of Raphael Wisniewski, Associate at Andera Partners
Your Intro Paths to Raphael Wisniewski
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Find Raphael Wisniewski on

cb
Current Investing Position
Andera Partners Associate
Investment Range
$5.0M - $35.0M
Sweet Spot
$20.0M
Investments On Record
16

Raphael Wisniewski is on these Sector & Stage Rankings

Raphael Wisniewski's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
ENYO Pharma
Series CJan 2024$43M
Series BJun 2018$47M
$90M
Co-investors: Carl Gordon (OrbiMed), Iain Dukes (OrbiMed)
BioVentrix
Series AApr 2023$49M
$49M
Andera Partners
Series AApr 2023$49M
$49M
SoniVie
Series CJan 2023$60M
$60M
Amolyt Pharma
Series CJan 2023$140M
$290M
Co-investors: Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital), Cedric Moreau (Soffinova Partners), Thierry Laugel (Kurma Partners), Ohad Hammer (Pontifax Venture Capital)
ImCheck Therapeutics
Series CJun 2022$100M
$180M
Co-investors: Michael Baran (Pfizer Venture Investments), Rémi Droller (Kurma Partners), Dr. Regina Hodits (Wellington Partners), Klaus Breiner (Pureos Bioventures), Florent Gros (Earlybird Venture Capital), Vincent Brichard
Exciva
Series AOct 2021$10M
$10M
Co-investors: Sofia Ioannidou (Andera Partners)
Artios Pharma
Series CJul 2021$150M
Series BAug 2018$83M
$270M
Co-investors: Hakan Goker (M Ventures (Merck)), René Kuijten (EQT Life Sciences), Florian Müllershausen (Novartis Venture Fund), Barbara Dalton (Pfizer Venture Investments)